All lobbying filings

Capitol Counsel LLC

Capitol Counsel LLC filed a registration for Madrigal Pharmaceuticals, Inc. on February 18, 2026.

Lobbying for Madrigal Pharmaceuticals, Inc. · Biopharmaceutical company.

As filed: CAPITOL COUNSEL LLC for MADRIGAL PHARMACEUTICALS, INC.

All filings by Capitol Counsel LLC · Everything Madrigal Pharmaceuticals, Inc. has reported

Filing · LD-1 registration Registration

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Feb 18, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 5

JEFFREY CARROLL New on this filing

Previously held: Staff Director House Energy and Commerce Committee; Chief of Staff, Rep. Frank Pallone.
ANN JABLON New on this filing

Previously held: Chief of Staff, Rep. Richard E. Neal; Legislative Director, Rep. Richard E. Neal; Administrative Assistant, Rep. Richard E. Neal; Executive/ Legislative Assistant, Rep. Richard E. Neal.
CHARLES PATRICK MICHAELS New on this filing

Previously held: Chief of Staff, Deputy Chief of Staff, Legislative Director, Senior Legislative Assistant, and Legislative Assistant, Rep. David Schweikert; Staff Assistant, Rep. Ted Budd; Intern, Senator James DeMint.
GEORGE SIFAKIS New on this filing

Previously held: Assistant to the President of the United States and Director of the Office of Public Liaison (President Trump, 2017).
JOHN MARTIN New on this filing

Previously held: Principal Associate Commissioner, FDA; Legislative Director, Sen. Tom Cotton; Legislative Assistant; Sen. Tom Cotton; Legislative Assistant, Representative Tom Cotton.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 3

Health Issues

FDA and regulatory issues related to the biopharmaceutical industry.

Medical/Disease Research/Clinical Labs

FDA and regulatory issues related to the biopharmaceutical industry.

Medicare/Medicaid

FDA and regulatory issues related to the biopharmaceutical industry.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.